THE FACT ABOUT WHAT ARE THE BEST NEUROPROTECTIVE DRUGS? THAT NO ONE IS SUGGESTING

Based upon the subgroup Evaluation, we uncovered that there was sizeable heterogeneity regarding mortality, favorable results, and the full treatment method effective level. Regarding mortality, The key reason why for heterogeneity on the subgroup of edaravone dexborneol and EDV was mainly attributed to differences in drug dosage. Relating to favor